Transcript: Thrombelastography (TEG 6s) early amplitudes predict maximum amplitude in severely injured trauma patients

[[RP_SECTION:early-clot-strength-prediction|Early Clot Strength Prediction]]

Alex: Early amplitude readings from thrombelastography — taken at five and ten minutes — turn out to be high-fidelity predictors of final clot strength in severely injured trauma patients. That's from a post-hoc analysis of the iTACTIC RCT, published in the Scandinavian Journal of Clinical and Laboratory Investigation. The implication is that you don't need to wait for the full assay to complete before making a treatment decision.

Sam: That's a meaningful compression of the diagnostic window. Why does this window exist at all? Why are clinicians waiting twenty minutes in the first place?

Alex: The standard assay requires the clot to reach a plateau — maximum amplitude — before you can confirm its final structural integrity. The clot is still forming, still crosslinking, and the trace hasn't stabilized. The protocol is built around that endpoint because it's the most reliable signal of where clot strength ultimately lands.

Sam: So the question the authors are really asking is: does the trajectory lock in early enough that you can act on it before the plateau?

Alex: Exactly. And the answer appears to be yes. By five minutes, the clot's developmental arc is essentially determined. If the early amplitude is low, the final amplitude will be low. The foundation predicts the finished building. [[RP_SECTION:predictive-performance-and-thresholds|Predictive Performance and Thresholds]]

Sam: What does the predictive performance actually look like?

Alex: The area under the ROC curve reached as high as 0.99 across the three assay types they tested — Kaolin, Rapid, and Functional Fibrinogen. That's a level of discrimination that's unusual for early-stage dynamic measurements. And critically, it held across all three assay variants, which suggests the finding isn't an artifact of one particular reagent chemistry.

Sam: Did they go further than AUC? Did they derive actionable thresholds?

Alex: They did. Using the Youden index, they calculated optimal cut-off values for each assay and timepoint. In the Kaolin assay, a five-minute amplitude below thirty-six millimeters was the optimal threshold for flagging low clot strength. That gives a clinician a concrete number rather than a gestalt impression. [[RP_SECTION:speed-versus-precision-tradeoffs|Speed Versus Precision Tradeoffs]]

Sam: And the ten-minute mark — is that just a later version of the same signal, or does it add something?

Alex: It adds specificity. The ten-minute marker tends to reduce false positives more effectively, which matters if your concern is unnecessary blood product administration. The five-minute marker is faster but slightly less specific. So the trade-off is speed versus precision, and the authors are reasonably explicit that the right choice depends on whether your clinical priority is time-to-treatment or avoiding overtransfusion.